Fe

Yalan Deng, Jiabing Huang, Changqing Chen, Yanbing Wen, Dongxu Qiu

Abstract read

In one paragraph

Article in Materials today. Bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Neuroform EZ stenting for basilar artery atherosclerotic stenosis.Scientific reports · 2025
Article
Degraded products generated by iron stent inhibit the vascular smooth muscle cell proliferation by downregulating AP-1.Journal of materials science. Materials in medicine · 2025
Article
SOX9 mediates the phenotypic transformation of vascular smooth muscle cells in restenosis after carotid artery injury.Frontiers in cell and developmental biology · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yalan DengDepartment of Ultrasonic Imaging, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.

Jiabing HuangDepartment of Cardiology, The Second Affiliated Hospital of Nanchang University, Jiangxi, Nanchang, PR China.

Changqing ChenDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR China.

Yanbing WenDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR China.

Dongxu QiuDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In-stent restenosis (ISR), caused by aggressive vascular smooth muscle cell (VSMC) proliferation, is a serious complication of stenting. Therefore, developing therapeutic approaches that target VSMC inhibition is imperative. Our previous study showed that VSMC hyperplasia was attenuated after iron stent degradation, and VSMC proliferation around the stented section was arrested. The corrosion products of the iron stents were primarily Fe

Indexed as

Cell proliferationFe3O4 particleNeointimal hyperplasiaVascular smooth muscle cell

Identifiers

PMID39027680

DOI10.1016/j.mtbio.2024.101133

PMCPMC11254736

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.